Pecato, Renneth L.
HRN: 23-58-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFUROXIME 500MG (TAB)
08/24/2023
08/31/2023
PO
500mg
BID X 7 Days
G1P0 36 2/7 Weeks AOG By LMP; Graves Disease, Impending Thyroid Storm; Preeclampsia Without Severe Features; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes